J
Jørgen Ingerslev
Researcher at Aarhus University Hospital
Publications - 159
Citations - 9532
Jørgen Ingerslev is an academic researcher from Aarhus University Hospital. The author has contributed to research in topics: Recombinant factor VIIa & Haemophilia. The author has an hindex of 46, co-authored 159 publications receiving 9059 citations. Previous affiliations of Jørgen Ingerslev include University of Sheffield & Royal Hallamshire Hospital.
Papers
More filters
Journal ArticleDOI
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
J E Sadler,U. Budde,Jeroen Eikenboom,Emmanuel J. Favaloro,Frank Hill,Lars Holmberg,Jørgen Ingerslev,Christine A. Lee,David Lillicrap,P. M. Mannucci,Claudine Mazurier,Dominique Meyer,William L. Nichols,M. Nishino,Ian R. Peake,F. Rodeghiero,Reinhard Schneppenheim,Zaverio M. Ruggeri,A. Srivastava,Robert R. Montgomery,Augusto B. Federici +20 more
TL;DR: Six categories of von Willebrand disease correlate with important clinical features and therapeutic requirements, and certain VWD types, especially type 1 and type 2A, encompass several pathophysiologic mechanisms that sometimes can be distinguished by appropriate laboratory studies.
Journal ArticleDOI
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.
Gilbert C. White,Frits R. Rosendaal,Louis M. Aledort,Jeanne M. Lusher,Chantal Rothschild,Jørgen Ingerslev +5 more
TL;DR: Definitions in Hemophilia - Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX and the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
Journal ArticleDOI
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)
Alberto Tosetto,Francesco Rodeghiero,Giancarlo Castaman,Anne Goodeve,Augusto B. Federici,Javier Batlle,Dominique Meyer,Edith Fressinaud,Claudine Mazurier,Jenny Goudemand,Jeroen Eikenboom,Reinhard Schneppenheim,U. Budde,Jørgen Ingerslev,Zdena Vorlova,David Habart,Lars Holmberg,Stefan Lethagen,John Pasi,Frank Hill,Ian R. Peake +20 more
TL;DR: Higher BS was related with increasing likelihood of VWD, and a mucocutaneous BS was strongly associated with bleeding after surgery or tooth extraction, which is potentially useful for a more accurate diagnosis of type 1 VWD.
Journal ArticleDOI
Phenotype and genotype of a cohort of families historically diagnosed with Type 1 von Willebrand Disease in the European study, molecular and clinical markers for the diagnosis and management of Type 1 von Willebrand Disease (MCMDM-1VWD)
Anne Goodeve,Jeroen Eikenboom,Giancarlo Castaman,Francesco Rodeghiero,Augusto B. Federici,Javier Batlle,Dominique Meyer,Claudine Mazurier,Jenny Goudemand,Reinhard Schneppenheim,Ulrich Budde,Jørgen Ingerslev,David Habart,Zdena Vorlova,Lars Holmberg,Stefan Lethagen,John Pasi,Frank Hill,Mohammad Hashemi Soteh,Luciano Baronciani,Christer Halldén,Andrea Guilliatt,Will Lester,Ian R. Peake +23 more
TL;DR: This study recruited families based on previous type 1 VWD diagnosis and stratified patients into those with or without phenotypes suggestive of qualitative VWF defects (abnormal multimers) and with or with mutations.
Journal ArticleDOI
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A
Angela Huth-Kühne,Francesco Baudo,Peter William Collins,Jørgen Ingerslev,Craig M. Kessler,Hervé Levesque,Maria Eva Mingot Castellano,Midori Shima,Jean St-Louis +8 more
TL;DR: Treatment guidance for acquired hemophilia A is provided, based on collective clinical experience in treating patients with AHA, to contribute to improved care for this patient group.